301 related articles for article (PubMed ID: 8187765)
1. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene.
Bodrug SE; Warner BJ; Bath ML; Lindeman GJ; Harris AW; Adams JM
EMBO J; 1994 May; 13(9):2124-30. PubMed ID: 8187765
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.
Lovec H; Grzeschiczek A; Kowalski MB; Möröy T
EMBO J; 1994 Aug; 13(15):3487-95. PubMed ID: 8062825
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 as the putative bcl-1 oncogene.
Harris AW; Bodrug SE; Warner BJ; Bath ML; Lindeman GJ; Adams JM
Curr Top Microbiol Immunol; 1995; 194():347-53. PubMed ID: 7895508
[No Abstract] [Full Text] [Related]
4. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia.
Robles AI; Larcher F; Whalin RB; Murillas R; Richie E; Gimenez-Conti IB; Jorcano JL; Conti CJ
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7634-8. PubMed ID: 8755527
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D and oncogenesis.
Motokura T; Arnold A
Curr Opin Genet Dev; 1993 Feb; 3(1):5-10. PubMed ID: 8453274
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
[TBL] [Abstract][Full Text] [Related]
8. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle.
Daksis JI; Lu RY; Facchini LM; Marhin WW; Penn LJ
Oncogene; 1994 Dec; 9(12):3635-45. PubMed ID: 7526316
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.
Musgrove EA; Lee CS; Buckley MF; Sutherland RL
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8022-6. PubMed ID: 8058751
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
Lovec H; Sewing A; Lucibello FC; Müller R; Möröy T
Oncogene; 1994 Jan; 9(1):323-6. PubMed ID: 8302597
[TBL] [Abstract][Full Text] [Related]
11. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc.
Haas K; Staller P; Geisen C; Bartek J; Eilers M; Möröy T
Oncogene; 1997 Jul; 15(2):179-92. PubMed ID: 9244353
[TBL] [Abstract][Full Text] [Related]
12. Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma.
Gladden AB; Woolery R; Aggarwal P; Wasik MA; Diehl JA
Oncogene; 2006 Feb; 25(7):998-1007. PubMed ID: 16247460
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
[TBL] [Abstract][Full Text] [Related]
14. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation.
Lukas J; Jadayel D; Bartkova J; Nacheva E; Dyer MJ; Strauss M; Bartek J
Oncogene; 1994 Aug; 9(8):2159-67. PubMed ID: 8036001
[TBL] [Abstract][Full Text] [Related]
15. Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma.
Uchimaru K; Taniguchi T; Yoshikawa M; Asano S; Arnold A; Fujita T; Motokura T
Blood; 1997 Feb; 89(3):965-74. PubMed ID: 9028328
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1/PRAD1 as a central target in oncogenesis.
Hosokawa Y; Arnold A
J Lab Clin Med; 1996 Mar; 127(3):246-52. PubMed ID: 9273357
[No Abstract] [Full Text] [Related]
17. Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation.
Uchimaru K; Endo K; Fujinuma H; Zukerberg L; Arnold A; Motokura T
Jpn J Cancer Res; 1996 May; 87(5):459-65. PubMed ID: 8641982
[TBL] [Abstract][Full Text] [Related]
18. Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1.
Lahti JM; Li H; Kidd VJ
J Biol Chem; 1997 Apr; 272(16):10859-69. PubMed ID: 9099742
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cell cycle entry and G1 progression by CSF-1.
Roussel MF
Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
[TBL] [Abstract][Full Text] [Related]
20. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.
Musgrove EA; Hamilton JA; Lee CS; Sweeney KJ; Watts CK; Sutherland RL
Mol Cell Biol; 1993 Jun; 13(6):3577-87. PubMed ID: 8497271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
